Skip to main content
. 2015 May 6;6(4):142–152. doi: 10.1007/s12672-015-0222-5

Table 2.

Estrous cycle analysis was performed just prior to collection of mice at 12 months of age

Genotype (no. of mice) % cycling Days to complete a cycle Days spent in stage(s) over estrous cycle
Proestrus Estrus Proestrus + estrus Metestrus Diestrus Metestrus + diestrus
C (N = 11) 63.6 4.3 ± 0.2 1.0 ± 0.0 1.1 ± 0.1 2.1 ± 0.1 1.1 ± 0.1 1.0 ± 0.0 2.1 ± 0.1
B (N = 9) 66.7 5.5 ± 0.3* 1.5 ± 0.2* 1.0 ± 0.3 2.5 ± 0.3 1.5 ± 0.2 1.5 ± 0.3 3.0 ± 0.4*
BT (N = 11) 63.6 4.3 ± 0.2 1.1 ± 0.1 1.1 ± 0.1 2.3 ± 0.2 1.0 ± 0.0 1.0 ± 0.0 2.0 ± 0.0
F (N = 10) 80.0 4.6 ± 0.3 1.0 ± 0.0 1.3 ± 0.2 2.3 ± 0.2 1.3 ± 0.2 1.1 ± 0.1 2.4 ± 0.2
BF (N = 10) 60.0 5.2 ± 0.3* 1.2 ± 0.2 1.2 ± 0.2 2.3 ± 0.2 1.5 ± 0.2 1.3 ± 0.2 2.8 ± 0.2*
BTF (N = 9) 66.7 5.0 ± 0.3 1.3 ± 0.2 1.2 ± 0.2 2.5 ± 0.2 1.3 ± 0.2 1.2 ± 0.2 2.5 ± 0.2

Follicular Brca1 GC−/− mutation alone or combined with Trp53 +/− and/or the presence of Tg.FSH had no effect on the ability of females to exhibit estrous cycling. Proestrus and cycle length were significantly longer in B versus C mice (one-way ANOVA, p < 0.05). Overall, there was no significant B genotype effect on estrous cycle or stages using all groups containing Brca1 GC−/− (two-way ANOVA, p = 0.06). Combined preovulatory stages (proestrus + estrus) were similar in all groups. Diestrus stage length was also equivalent in all groups. Combined post-ovulatory (metestrus + diestrus) stage times were longer in the B and BF groups (one-way ANOVA p < 0.05). *p < 0.05, one-way ANOVA